Nature, Published online: 28 October 2026; doi:10.1038/s41586-026-11208-w

Tumour assembloids, which model components of human renal cell carcinoma, including cancer cells, cancer-associated fibroblasts and tumour-infiltrating immune cells, are used to identify an essential pathway that mediates heterogeneous therapeutic responses.